Trevena Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | Buy/Sell | $174.55 | 9.93% | 3 | $372.17B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$30.82 | Buy/Sell | $47.90 | 42.76% | 6 | $1.23B |
| HRTX | Heron Therapeutics | Buy |
7
|
$3.20 | Buy/Sell | $5.63 | 103.13% | 0 | $442.92M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | Buy/Sell | $8.50 | -100.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | Outperform |
6
|
$1.08 | Buy/Sell | $4.63 | 293.52% | 0 | $17.33M |
| BXRX | Baudax Bio | - |
0
|
$0.01 | Buy/Sell | $24.00 | -100.00% | 0 | $1.16M |